Agios Pharmaceuticals price target raised to $55 from $52 at H.C. Wainwright
Bullish target upgrade; near-term upside expected.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish target upgrade; near-term upside expected.
What happened, with direct paths to the underlying reporting
AGIO price target raised to $55 from $52 by H.C. Wainwright; current price around $32.93.
Target: $55
Posted price: $32.93
Analyst firm: H.C. Wainwright
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.